Marksans Pharma Dividend
Dividend criteriumcontroles 2/6
Marksans Pharma is a dividend paying company with a current yield of 0.21% that is well covered by earnings.
Belangrijke informatie
0.2%
Dividendrendement
0.05%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 0.3% |
| Toekomstig dividendrendement | 1.2% |
| Dividendgroei | 5.2% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | ₹0.600 |
| Uitbetalingsratio | 9% |
Recente dividendupdates
Recent updates
Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?
Oct 24
Optimistic Investors Push Marksans Pharma Limited (NSE:MARKSANS) Shares Up 45% But Growth Is Lacking
Sep 21Marksans Pharma Limited (NSE:MARKSANS) Stock Rockets 26% But Many Are Still Ignoring The Company
Jul 28Solid Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)
Jun 07Does Marksans Pharma (NSE:MARKSANS) Deserve A Spot On Your Watchlist?
May 31Sentiment Still Eluding Marksans Pharma Limited (NSE:MARKSANS)
Feb 16Here's Why Marksans Pharma (NSE:MARKSANS) Has Caught The Eye Of Investors
Jan 26We Think Marksans Pharma (NSE:MARKSANS) Can Manage Its Debt With Ease
Dec 02Marksans Pharma (NSE:MARKSANS) Seems To Use Debt Quite Sensibly
Jun 21Robust Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)
Nov 17This Is The Reason Why We Think Marksans Pharma Limited's (NSE:MARKSANS) CEO Deserves A Bump Up To Their Compensation
Sep 16Marksans Pharma (NSE:MARKSANS) Is Increasing Its Dividend To ₹0.25
Sep 01Marksans Pharma (NSE:MARKSANS) Could Easily Take On More Debt
Jun 14Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?
May 27Is Marksans Pharma (NSE:MARKSANS) A Risky Investment?
Feb 19Marksans Pharma Limited's (NSE:MARKSANS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 04Here's Why We Think Marksans Pharma (NSE:MARKSANS) Is Well Worth Watching
Jan 20Do Institutions Own Marksans Pharma Limited (NSE:MARKSANS) Shares?
Jan 05
Shareholders Are Thrilled That The Marksans Pharma (NSE:MARKSANS) Share Price Increased 250%
Dec 21What Can We Conclude About Marksans Pharma's (NSE:MARKSANS) CEO Pay?
Dec 06These 4 Measures Indicate That Marksans Pharma (NSE:MARKSANS) Is Using Debt Safely
Nov 19Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: MARKSANS's dividend payments have been volatile in the past 10 years.
Groeiend dividend: MARKSANS's dividend payments have increased over the past 10 years.
Dividendrendement versus markt
| Marksans Pharma Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (MARKSANS) | 0.2% |
| Markt onderkant 25% (IN) | 0.2% |
| Markt Top 25% (IN) | 1.1% |
| Gemiddelde industrie (Pharmaceuticals) | 0.7% |
| Analist prognose (MARKSANS) (tot 3 jaar) | 1.2% |
Opmerkelijk dividend: MARKSANS's dividend (0.21%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.24%).
Hoog dividend: MARKSANS's dividend (0.21%) is low compared to the top 25% of dividend payers in the Indian market (1.09%).
Winstuitkering aan aandeelhouders
Verdiendekking: With its low payout ratio (8.7%), MARKSANS's dividend payments are thoroughly covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: With its high cash payout ratio (126.1%), MARKSANS's dividend payments are not well covered by cash flows.